r2mpharma.com | R2M Pharma | South San Francisco

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
User-agent: * Allow: / # Optimization for Google Ads Bot User-agent: AdsBot-Google-Mobile User-agent: AdsBot-Google Disallow: /_api/* Disallow: /_partials* Disallow: /pro-gallery-webapp/v1/galleries/* # Block PetalBot User-agent: PetalBot Disallow: / Sitemap: https://www.r2mpharma.com/sitemap.xml # Auto generated, go to SEO Tools > Robots.txt Editor to change

Meta Tags

Title	R2M Pharma \| South San Francisco \| Accelerating Drug
Description	R2M Pharma \| Accelerating Drug Discovery \| 600 Gateway Blvd., South San Francisco,
Keywords	N/A

Server Information

WebSite	r2mpharma.com
Host IP	23.236.62.147
Location	United States

Related Websites

                        Site
                        Rank
                    

More to Explore

r2mpharma.com Valuation

US$1,470

Last updated: 2023-05-20 04:51:31

r2mpharma.com has Semrush global rank of 0. r2mpharma.com has an estimated worth of US$ 1,470, based on its estimated Ads revenue. r2mpharma.com receives approximately 169 unique visitors each day. Its web server is located in United States, with IP address 23.236.62.147. According to SiteAdvisor, r2mpharma.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$1,470
Daily Ads Revenue	US$1
Monthly Ads Revenue	US$40
Yearly Ads Revenue	US$488
Daily Unique Visitors	11
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
r2mpharma.com.	A	3600	IP: 23.236.62.147
r2mpharma.com.	NS	3600	NS Record: ns57.domaincontrol.com.
r2mpharma.com.	NS	3600	NS Record: ns58.domaincontrol.com.
r2mpharma.com.	MX	3600	MX Record: 0 r2mpharma-com.mail.protection.outlook.com.
r2mpharma.com.	TXT	3600	TXT Record: v=spf1 ip4:67.207.112.142 include:spf.protection.outlook.com -all

HtmlToTextCheckTime:2023-05-20 04:51:31

top of page Home About Us Team Services News Patents Contact LinkedIn Accelerating Drug Discovery “The R2M team worked with Tenaya to accelerate lead optimization in our small molecule drug development programs. R2M was a great resource for us a start-up biotech company without internal medicinal chemistry expertise. They supported target validation, compound optimization, DMPK and patent strategy needs in a very professional and efficient manner. R2M has an experienced, productive, and results-oriented team and are great to work with.” Timothy Hoey, Ph.D. Chief Scientific Officer Tenaya Therapeutics, Inc. bottom of

HTTP Headers

HTTP/1.1 301 Moved Permanently
Date: Tue, 10 Jan 2023 08:58:52 GMT
Content-Length: 0
Connection: keep-alive
location: https://www.r2mpharma.com/
strict-transport-security: max-age=3600
Age: 30248
Server-Timing: cache;desc=hit, varnish;desc=hit, dc;desc=uw2-pub-1
X-Seen-By: hb2+EPh7fPdW2+vqbvCmcanPWIDxfKj16yM6xXYJ3IE=,GXNXSWFXisshliUcwO20Naon851uhK6HRsxREnrEO9asn5WjbOcu3V3y9B6sMFtNmuOkfcTSJaUOHlD2KQbqrA==,m0j2EEknGIVUW/liY8BLLrS/q53T25jsaPnfPkSVOt8m++C2XkuTvnlRFg2XiSDL,2d58ifebGbosy5xc+FRallrqqeL0j05yJBozQM4CUCX3csuk4NtduFgKTUpW0qg2NsxUT/CVZBBkUQtVu270XA==,2UNV7KOq4oGjA5+PKsX47O6uVG6buAunlWjI2L90d5VjPZTuGyYqVhtmEIgJUb4w
Cache-Control: no-cache
X-Wix-Request-Id: 1673341132.065310853229137
X-Content-Type-Options: nosniff

HTTP/2 200 
date: Tue, 10 Jan 2023 08:58:52 GMT
content-type: text/html; charset=UTF-8
link: ; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,
x-wix-request-id: 1673341132.29140032416585
content-language: en
strict-transport-security: max-age=3600
age: 0
x-seen-by: GXNXSWFXisshliUcwO20NXdyD4zpCpFzpCPkLds0yMeFKHPPVGqP5QZCTlAByKCi,qquldgcFrj2n046g4RNSVIrig9SAqnXW0O7zAzsQkQs=,2d58ifebGbosy5xc+FRalj/xqRQt4kNvTodFqlisvBWsA2BpNdy3OpII1bYHrQQWIfmLvG9NAENrGV7lk37nh92Bi/n1A70o2Rt9TPUj3u8=,2UNV7KOq4oGjA5+PKsX47NTaFvZEsXIsLVjEfrvlXStWd3xniMsr1HjrszKGvMzr,7npGRUZHWOtWoP0Si3wDp7zT5RIk4Gbggt5/mHmXvRE=,k/eiGVUYmmiydpksa5zLSWXOeNPcugyuXbBuZg657tmVGutIoXfcyva5uBKD1ydXWIHlCalF7YnfvOr2cMPpyw==,xTu8fpDe3EKPsMR1jrheEL4QCbqKafCRbcnG9LYPPzw=,LoUK8/saGAmOxZWtpubo2gJGZ5aJ883Bogv1631MLoAGRufcbFuuRLlqv7E+nnEohNF5VoA8y8aNNs4ajmJ1xA==,xTu8fpDe3EKPsMR1jrheEEJSCMgS/OlQH7vylhNe2tU=,xTu8fpDe3EKPsMR1jrheELSPVzXcOAnby6LRq+ehPgw=,/a5ccLSK1HEmwPNg/x6OukIT+c5HqyHveWvXmN7dchp68WxB1+nwJNJTsRxdC2wm2c90pmU1bEa+D2nYqAqLJ+3m13kdyvfafqCEmOuW2/E=
cache-control: no-cache
vary: Accept-Encoding
accept-ranges: bytes
set-cookie: ssr-caching=cache#desc=miss#varnish=miss#dc#desc=euw3_g; Max-Age=20; Expires=Tue, 10 Jan 2023 08:59:12 GMT
server-timing: cache;desc=miss, varnish;desc=miss, dc;desc=euw3_g
x-content-type-options: nosniff
server: Pepyaka/1.19.10
via: 1.1 google
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"

r2mpharma.com valuation and analysis